Novel antibody–drug conjugates for triple negative breast cancer

Triple negative breast cancer (TNBC) is a heterogenous subtype of breast cancer often associated with an aggressive phenotype and poor prognosis. Antibody–drug conjugate (ADC), comprising of a monoclonal antibody linked to a cytotoxic payload by a linker, is gaining increasing traction as an anti-ca...

Descripción completa

Detalles Bibliográficos
Autores principales: Nagayama, Aiko, Vidula, Neelima, Ellisen, Leif, Bardia, Aditya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2020
Materias:
TNBC in 2019: Promising Signals for the Special Collection Treatment of a Formidable Disease
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7222243/
https://www.ncbi.nlm.nih.gov/pubmed/32426047
http://dx.doi.org/10.1177/1758835920915980

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7222243/
https://www.ncbi.nlm.nih.gov/pubmed/32426047
http://dx.doi.org/10.1177/1758835920915980

Ejemplares similares